INVESTMENTS IN INNOVATION

QNBV

Gregor Diagnostics Inc.

Biosciences/Medical Devices

504 South Rosa Road STE 200
Madison, 53719
United States

Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer. Gregor’s patient-friendly test will be the first diagnostic to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. This will result in decreased overdiagnosis and overtreatment of indolent prostate cancer, and more effective detection of aggressive prostate cancer